The EEB and MPP welcomed a new study for the European Commission, which recommends phasing out dental amalgam use in five years. The BIOS report noted that mercury-free fillings appear more expensive than amalgam because the negative external costs associated with management of amalgam are not factored in. MPP director Bender discussed the EU study in a recent youtube interview, and also said that “When factoring in external costs to society, the average price of an amalgam would be 15% higher than that of a composite,” referencing a recent study on the The Real Cost of Dental Mercury.
Joined by the EU, Canada and other developed countries, the U.S. opposed a separate health provision during the fourth (of five) mercury treaty negotiation earlier this week in Punta del Este, Uruguay. “This is an example of north–south double standard over whether health issues will be addressed equitably,” stated Michael Bender , MPP director, who provided a statement on behalf of the Zero Mercury Working Group during the negotiation. “Mercury is a basic human rights issue. Health strategies to address reducing exposure to mercury must be included in this treaty.”
Governments meeting at the 4th of 5 negotiations are running out of time to address key issues before finalizing a legally binding treaty on mercury. Most major issues remain unresolved and the Zero Mercury Working Group expressed concern over the lack of progress at such a late stage. “There has been no substantial progress on the biggest sources of mercury pollution nor in reconciling the different positions of governments,” said Michael Bender, ZMWG co-coordinator. Issues as straightforward as the phase out of mercury in products and processes and supply and trade did not progress any better, according to Bender. Barely visible in the draft treaty text are core requirements for the environmentally sound management of mercury, which are contingent on future decisions, and the issue of contaminated sites has only been minimally addressed.